Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77 Higashinaniwa-cho, Amagasaki 6608550, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 1130033, Japan.
Eur Heart J Acute Cardiovasc Care. 2022 Jun 7;11(4):312-321. doi: 10.1093/ehjacc/zuac011.
Several studies have reported a high predictive ability of the Sequential Organ Failure Assessment (SOFA) score for in-hospital mortality specifically for patients with cardiac critical illnesses, however, differences according to the admission classification (surgical or non-surgical) are unknown. The present study aimed to evaluate the predictive ability of the SOFA score in surgical and non-surgical patients with cardiac critical illnesses.
Using the Japanese nationwide Diagnosis Procedure Combination database, we identified patients with cardiac critical illnesses, defined as patients admitted to the intensive care unit (ICU) and treated by cardiologists or cardiovascular surgeons as their physicians in charge from April 2018 to March 2020. The discriminatory ability of the SOFA score for in-hospital mortality was assessed by calculating the area under the receiver operating characteristic curve (AUROC). Among 52 819 eligible patients with available data on their SOFA scores, 33 526 (64%) were postoperative cardiac surgeries. The median SOFA score on ICU admission was 5.0 (interquartile range, 2.0-8.0) and overall in-hospital mortality 6.8%. The AUROC of the SOFA score was 0.75 [95% confidence interval (CI), 0.75-0.76]. In the subgroup analyses, the AUROCs were 0.76 (95% CI, 0.74-0.77) in the surgical patients, 0.83 (95% CI, 0.83-0.84) in the non-surgical patients, and 0.88 (95% CI, 0.87-0.89) in the non-surgical acute coronary syndrome patients.
The predictive ability of the SOFA score on the day of ICU admission for in-hospital mortality was confirmed to be acceptable in the patients with cardiac critical illnesses and varied according to the admission classification and primary diagnoses.
几项研究报告称,序贯器官衰竭评估(SOFA)评分对心脏危重症患者的院内死亡率具有较高的预测能力,然而,其根据入院分类(手术或非手术)的差异尚不清楚。本研究旨在评估 SOFA 评分在心脏危重症手术和非手术患者中的预测能力。
我们使用日本全国诊断程序组合数据库,确定了心脏危重症患者,定义为 2018 年 4 月至 2020 年 3 月期间因心脏疾病入住重症监护病房(ICU)并由心脏病专家或心血管外科医生作为主治医生进行治疗的患者。通过计算接受者操作特征曲线下的面积(AUROC)来评估 SOFA 评分对院内死亡率的预测能力。在 52819 名符合条件的患者中,有 33526 名(64%)为术后心脏手术。ICU 入院时的中位 SOFA 评分为 5.0(四分位间距,2.0-8.0),总体院内死亡率为 6.8%。SOFA 评分的 AUROC 为 0.75(95%置信区间,0.75-0.76)。在亚组分析中,手术患者的 AUROC 为 0.76(95%置信区间,0.74-0.77),非手术患者为 0.83(95%置信区间,0.83-0.84),非手术急性冠状动脉综合征患者为 0.88(95%置信区间,0.87-0.89)。
SOFA 评分在 ICU 入院当天对心脏危重症患者的院内死亡率的预测能力被证实是可以接受的,并且根据入院分类和主要诊断而有所不同。